XIVOLRIS
Live / Applied — Fourth extension granted (statement of use) (as of 19 Nov 2025)
What this means for you
Not registered yet, but its 21 Jul 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97514100
- Mark type
- Stylized text
- Filed
- 21 Jul 2022
- Published for opposition
- 19 Dec 2023
- Attorney of record
- Makiko Coffland
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the prevention and the treatment of cancer, orphan diseases, immune disorders, liver diseases, biliary diseases, metabolic diseases, inflammatory diseases, urological diseases, disorders and diseases of the reproductive system, puberty diseases or disorders, gynecological disorders, fertility, acromegalia and tumors, hormonal disorders, endocrine disorders, connective tissue diseases, blood diseases, gastrointestinal diseases and disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases, muscle disorders, bone disorders, skeletal disorders, neuromuscular disorders, cervical dystonia, cerebral palsy, spasticity, blepharospasm, migraine, bladder pain syndrome, pain, glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; pharmaceutical preparations containing botulinum toxin, botulinum toxin-haemagglutinin complex, botulinum toxin fragments and other botulinum toxin derivatives for skin care and the treatment of neurological disorders; pharmaceutical preparations containing botulinum toxin with specified component of the toxin haemagglutinin complex for skin care and the treatment of neurological disorders
Owner
- Clementia Pharmaceuticals Inc., Montreal, Quebec, CA
- Clementia Pharmaceuticals Inc., Montreal, Quebec, CA
Prosecution history
- 20 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Nov 2025 — SOU EXTENSION 4 GRANTED
- 19 Nov 2025 — SOU EXTENSION 4 FILED
- 19 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 17 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 May 2025 — SOU EXTENSION 3 GRANTED
- 16 May 2025 — SOU EXTENSION 3 FILED
- 16 May 2025 — SOU TEAS EXTENSION RECEIVED
- 29 Jan 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Jan 2025 — SOU EXTENSION 2 GRANTED
- 15 Nov 2024 — SOU EXTENSION 2 FILED
- 28 Jan 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 16 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Jul 2024 — SOU EXTENSION 1 GRANTED